What medication is used to treat neurofibromas?: A Guide to FDA-Approved MEK Inhibitors
•
2 min read
As of early 2025, two MEK inhibitor medications have received FDA approval for the treatment of certain neurofibromas. The advent of these drugs has transformed the treatment landscape for individuals with neurofibromatosis type 1 (NF1), offering a targeted, non-surgical option for specific tumor types. This is a significant shift from previous approaches and addresses the key question of **what medication is used to treat neurofibromas?**
